Sanjay Subramanian

CIK: 0001790246

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

SCYX

SCYNEXIS INC

Officer

INZY

Inozyme Pharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

SCYX
SCYNEXIS INC
Sep 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
INZY
Inozyme Pharma, Inc.
Jul 1, 2025
Tender Offer(U)
Direct
39.7K shares at avg. $4.00$159K
INZY
Inozyme Pharma, Inc.
Jul 1, 2025
Disposition(D)
Restricted Stock Units
Direct
38.5K shares-
INZY
Inozyme Pharma, Inc.
Jul 1, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
180K shares-
INZY
Inozyme Pharma, Inc.
Jul 1, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
135K shares-
INZY
Inozyme Pharma, Inc.
Jul 1, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
145K shares-
INZY
Inozyme Pharma, Inc.
Jun 25, 2025
Award(A)
Direct
6.8K shares at avg. $0.74$5K
INZY
Inozyme Pharma, Inc.
Mar 31, 2025
Award(A)
Direct
2.5K shares at avg. $0.77$2K
INZY
Inozyme Pharma, Inc.
Mar 11, 2025
Award(A)
Stock Option (right to buy)
Direct
145K shares-
INZY
Inozyme Pharma, Inc.
Mar 11, 2025
Award(A)
Restricted Stock Units
Direct
38.5K shares-

		Type	Shares	Price		Ownership
Sep 9, 2026	SCYX SCYNEXIS INC	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Jul 1, 2025	INZY Inozyme Pharma, Inc.	Tender Offer(U)	39,701	$4.00	$158,804	Direct
Jul 1, 2025	INZY Inozyme Pharma, Inc.	Disposition(D) Restricted Stock Units	38,500	-	-	Direct
Jul 1, 2025	INZY Inozyme Pharma, Inc.	Disposition(D) Stock Option (Right to Buy)	180,000	-	-	Direct
Jul 1, 2025	INZY Inozyme Pharma, Inc.	Disposition(D) Stock Option (Right to Buy)	135,000	-	-	Direct
Jul 1, 2025	INZY Inozyme Pharma, Inc.	Disposition(D) Stock Option (Right to Buy)	145,000	-	-	Direct
Jun 25, 2025	INZY Inozyme Pharma, Inc.	Award(A)	6,813	$0.74	$5,042	Direct
Mar 31, 2025	INZY Inozyme Pharma, Inc.	Award(A)	2,490	$0.77	$1,917	Direct
Mar 11, 2025	INZY Inozyme Pharma, Inc.	Award(A) Stock Option (right to buy)	145,000	-	-	Direct
Mar 11, 2025	INZY Inozyme Pharma, Inc.	Award(A) Restricted Stock Units	38,500	-	-	Direct

1-10 of 10 transactions

About Subramanian Sanjay

Subramanian Sanjay (SEC CIK 0001790246) files insider reports with the SEC as Chief Financial Officer of SCYNEXIS INC (SCYX) and SVP, CFO of Inozyme Pharma, Inc. (INZY).

Signal8 holds 6 ownership filings by Subramanian Sanjay (1 Form 3, 5 Form 4), filed between Mar 17, 2025 and Sep 11, 2026. Those filings report 10 transactions, from Mar 11, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Subramanian Sanjay's filings is in JERSEY CITY, NJ.

Recent filings by Subramanian Sanjay

Sep 9, 2026: Grant or award of SCYX derivative securities (Form 4, code A).
Jul 1, 2025: Tender of shares transaction of INZY shares (Form 4, code U).
Jul 1, 2025: Disposition to issuer transactions of INZY derivative securities (4 lines, Form 4, code D).
Jun 25, 2025: Grant or award of INZY shares (Form 4, code A).
Mar 31, 2025: Grant or award of INZY shares (Form 4, code A).

Other insiders filing for SCYNEXIS INC (SCYX)

How to read Form 4 transaction codes